KD01

AXP000058.1 · Oncolytic virus

Platform
adenovirus
Originator
Tongji Hospital, Huazhong University of Science and Technology
Sponsor
Tongji Hospital, Huazhong University of Science and Technology

Names

NameTypeSource
KD01 ambiguouspreferred name, codecurator, ctgov

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus (serotype not reported)
Replication
conditionally replicating
Route
intratumoral
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (2)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07359235Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)RecruitingPhase 12024-11-042028-12-3129Bladder Cancer (BC)
NCT06552598The Safety, Tolerability, and Efficacy of KD01 in Gynecologic MalignanciesRecruitingPhase 12024-04-012028-04-0197Cervical Cancer; Endometrial Cancer; Gynecologic Malignancies

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 41761958Bevacizumab-Primed Vascular Normalization Enhances Intratumoral Delivery and Efficacy of the tBID-Armed Oncolytic Adenovirus KD01 in Glioma.Frontiers in bioscience (Landmark edition)2026name in title: KD01
PMID 42989365TBID-armed oncolytic adenovirus KD01 engages a CDCA8-associated mitotic vulnerability for anti-glioma therapy.Virology journal2026name in title: KD01
PMID 40033102Ferroptosis enhances the therapeutic potential of oncolytic adenoviruses KD01 against cancer.Cancer gene therapy2025name in title: KD01
PMID 40283946Preclinical Efficacy and Safety of an Oncolytic Adenovirus KD01 for the Treatment of Bladder Cancer.Pharmaceuticals (Basel, Switzerland)2025name in title: KD01
PMID 38734262Degradation of organic mercury in high salt environments by a marine aerobic bacterium Alteromonas macleodii KD01.Bioresource technology2024name in title: KD01
PMID 38007712Superoxide-Mediated Extracellular Mercury Reduction by Aerobic Marine Bacterium Alteromonas sp. KD01.Environmental science & technology2023name in title: KD01
Unconfirmed matches (2)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 40057574Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency.Cancer gene therapy2025name in abstract: KD01
PMID 40813343Discovery of asymmetric pyridinium-based fluorescent probes with large Stokes shifts for live neural stem/progenitor cells.Journal of materials chemistry. B2025name in abstract: KD01

Notes

Recombinant oncolytic adenovirus in phase I trials in gynaecological malignancies (NCT06552598) and a second Tongji trial (NCT07359235); preclinical work also in bladder cancer. Construct not described in sources consulted.

How to cite

KD01 (AXP000058.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000058.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.